Qifeng Qiu

1.3k total citations
11 papers, 709 citations indexed

About

Qifeng Qiu is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Qifeng Qiu has authored 11 papers receiving a total of 709 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 4 papers in Molecular Biology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Qifeng Qiu's work include HER2/EGFR in Cancer Research (6 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Genomics and Chromatin Dynamics (3 papers). Qifeng Qiu is often cited by papers focused on HER2/EGFR in Cancer Research (6 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Genomics and Chromatin Dynamics (3 papers). Qifeng Qiu collaborates with scholars based in United States and Switzerland. Qifeng Qiu's co-authors include M. Mitchell Smith, Patrick A. Grant, Marilyn G. Pray-Grant, Paul C. Megee, Michael F. Christman, Alexander W. Bird, Thomas A. Keating, John R. Yates, Jeffrey Shabanowitz and Scott Anderson and has published in prestigious journals such as Nature, Nature Cell Biology and Cancer Research.

In The Last Decade

Qifeng Qiu

11 papers receiving 702 citations

Peers

Countries citing papers authored by Qifeng Qiu

Since Specialization

Citations

This map shows the geographic impact of Qifeng Qiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qifeng Qiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qifeng Qiu more than expected).

Fields of papers citing papers by Qifeng Qiu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qifeng Qiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qifeng Qiu. The network helps show where Qifeng Qiu may publish in the future.

Co-authorship network of co-authors of Qifeng Qiu

This figure shows the co-authorship network connecting the top 25 collaborators of Qifeng Qiu. A scholar is included among the top collaborators of Qifeng Qiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qifeng Qiu. Qifeng Qiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	Increased Tumor Penetration of Single-Domain Antibody–Drug Conjugates Improves In Vivo Efficacy in Prostate Cancer Models 2020 ·Cancer Research ·Ian Nessler, Eshita Khera, (unknown), (unknown), Qifeng Qiu, Thomas A. Keating, Adnan O. Abu‐Yousif, Thomas Sandal, James Legg, (unknown), Normann Goodwin, Greg M. Thurber	87
2	Abstract 2890: IMGN151 - A next generation folate receptor alpha targeting antibody drug conjugate active against tumors with low, medium and high receptor expression 2020 ·Cancer Research ·Olga Ab, Laura M. Bartle, Leanne Lanieri, Jose F. Ponte, Qifeng Qiu, (unknown), (unknown), (unknown), Nicholas C. Yoder, Wayne C. Widdison, (unknown), (unknown), Ying Chen, Neeraj Kohli, Thomas Chittenden, Richard J. Gregory, Yulius Y. Setiady, Eric H. Westin	10
3	The novel CD19-targeting antibody-drug conjugate huB4-DGN462 shows improved anti-tumor activity compared to SAR3419 in CD19-positive lymphoma and leukemia models 2019 ·Haematologica ·Stuart W. Hicks, Chiara Tarantelli, (unknown), Eugenio Gaudio, Min Li, Alberto J. Arribas, Filippo Spriano, Roberta Bordone, Luciano Cascione, Katharine C. Lai, Qifeng Qiu, Monica Taborelli, Davide Rossi, Georg Stüssi, Emanuele Zucca, Anastasios Stathis, Callum M. Sloss, Francesco Bertoni	18
4	Peptide-Cleavable Self-immolative Maytansinoid Antibody–Drug Conjugates Designed To Provide Improved Bystander Killing 2019 ·ACS Medicinal Chemistry Letters ·(unknown), (unknown), Qifeng Qiu, Jose F. Ponte, Leanne Lanieri, Yulius Y. Setiady, Ling Dong, Anna Skaletskaya, Laura M. Bartle, (unknown), (unknown), Erin K. Maloney, Yelena Kovtun, Olga Ab, (unknown), Ravi Chari, Wayne C. Widdison	18
5	Synthesis and Evaluation of Camptothecin Antibody–Drug Conjugates 2019 ·ACS Medicinal Chemistry Letters ·Wěi Li, (unknown), Qifeng Qiu, Kerstin W. Sinkevicius, Erin K. Maloney, (unknown), Janet Lau, Helen L. Evans, Yulius Y. Setiady, Olga Ab, (unknown), Jenny Lee, (unknown), Anna Skaletskaya, Lintao Wang, Thomas A. Keating, Ravi Chari, Wayne C. Widdison	30
6	Abstract 53: Antibody-drug conjugates (ADCs) of peptide-linked Indolino-Benzodiazepine (IGN) DNA-alkylator provides improved anti-tumor activity over that of a crosslinker 2017 ·Cancer Research ·Michael L. Miller, (unknown), Jose F. Ponte, Leanne Lanieri, Dilrukshi Vitharana, Qifeng Qiu, (unknown), Katie E. Archer, Rui Wu, Erin K. Maloney, Olga Ab, Jan Pinkas, Ravi Chari	1
7	Abstract 2651: A novel CD19 targeting antibody-drug conjugate, huB4-DGN462, shows promising in vitro and in vivo activity in CD19-positive lymphoma models 2017 ·Cancer Research ·Eugenio Gaudio, Chiara Tarantelli, Alberto J. Arribas, Roberta Bordone, Andrea Rinaldi, Georg Stüssi, Emanuele Zucca, Davide Rossi, Anastasios Stathis, Min Li, (unknown), (unknown), Qifeng Qiu, Stuart W. Hicks, Callum M. Sloss, Francesco Bertoni	3
8	Abstract 2186: Peptide-cleavable maytansinoid (ADCs) induce high bystander killing leading to improved anti-tumor activity in vivo 2017 ·Cancer Research ·Wayne C. Widdison, (unknown), Jose F. Ponte, Leanne Lanieri, Yulius Y. Setiady, Ling Dong, Anna Skaletskaya, (unknown), Qifeng Qiu, Yelena Kovtun, Ravi Chari	1
9	Histone H3 Thr 45 phosphorylation is a replication-associated post-translational modification in S. cerevisiae 2010 ·Nature Cell Biology ·Stephen P. Baker, (unknown), Scott Anderson, Qifeng Qiu, Jeffrey Shabanowitz, M. Mitchell Smith, John R. Yates, Donald F. Hunt, Patrick A. Grant	70
10	Catalytic-Site Mutations in the MYST Family Histone Acetyltransferase Esa1 2008 ·Genetics ·(unknown), (unknown), Masayoshi Iizuka, Qifeng Qiu, M. Mitchell Smith	30
11	Acetylation of histone H4 by Esa1 is required for DNA double-strand break repair 2002 ·Nature ·Alexander W. Bird, (unknown), Marilyn G. Pray-Grant, Qifeng Qiu, (unknown), Paul C. Megee, Patrick A. Grant, M. Mitchell Smith, Michael F. Christman	441

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact